Abstract:Background: Centromere protein M (CENPM) has been reported to exert important roles in promoting tumor initiation and progression. However, the expression, effect, impact on prognosis and underlying mechanism of CENPM in lung adenocarcinoma (LUAD) remain unclear. Methods: Seventy-eight paired clinical samples of LUAD and corresponding adjacent non-tumor (ANT) tissues were obtained. The clinical pathological data and clinical outcome were tested, including univariate and multivariate Cox regression model. The relationship between CENPM expression and LUAD prognosis were identified according to the data obtained from the Cancer Genome Atlas (TCGA) database. Then, we explored the protein and mRNA levels of CENPM in LUAD and paired ANT tissues, and analyzed the correlation between CENPM and LUAD overall survival in our patients. In vitro studies, LUAD cell lines were treated with CENPM-short hairpin RNA (shRNA) (shCENPM), or transfected with CENPM overexpression plasmids with or without LY294002 (PI3K inhibitor) treatment. Cell proliferation ability was determined through cell counting kit-8 (CCK- 8) assays. Cell cycle and apoptosis were detected by flow cytometer. The migration and invasion ability were assessed through Transwell assay. In vivo studies, the growth of xenografts in nude mice were evaluated after shCENPM stimulated cells injection, and the proliferation and apoptosis of xenografts were also analyzed. Results: CENPM was significantly upregulated in LUAD patients compared with healthy controls, and CENPM upregulation was relevant to the higher pathological stages and poor survival rates in our LUAD patients. The bioinformatics analysis also revealed similar trends. CENPM could promote cell proliferation, cause alterations in cell cycle progression, enhance cell migration and invasion capacity, promote apoptosis in LUAD cell lines and promote the growth of xenografts in nude mice via regulation of AKT1/mTOR signaling pathway. Conclusions: CENPM was upregulated in LUAD patients, and it correlated with higher pathological stages and poor survival rates. CENPM could affect cell proliferation, cell cycle, cell migration and invasion capacity, and apoptosis in LUAD cell lines via regulation of AKT1/mTOR signaling pathway.

The Prognostic Value and Mechanisms of Centromere Protein M in Patients with Lung Adenocarcinoma

CENPH Overexpression Promotes the Progression, Cisplatin Resistance, and Poor Prognosis of Lung Adenocarcinoma Via the AKT and ERK/P38 Pathways.

Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.

NPM3 As a Novel Oncogenic Factor and Poor Prognostic Marker Contributes to Cell Proliferation and Migration in Lung Adenocarcinoma

A Five-Gene Expression Signature of Centromeric Proteins with Prognostic Value in Lung Adenocarcinoma.

P2.03-49 Roles of CENPU in Lung Adenocarcinoma Progression and Invasion

The Centromere-Associated Protein CENPU Promotes Cell Proliferation, Migration, and Invasiveness in Lung Adenocarcinoma.

Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma

Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer

Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker

CENPE Promotes Lung Adenocarcinoma Proliferation and is Directly Regulated by FOXM1

Downregulation of CENPK Suppresses Lung Adenocarcinoma by Regulating EMT

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis

CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle

High expression of centromere protein A and its molecular mechanism and clinical significance in prostate cancer: A study based on data mining and immunohistochemistry

Comprehensive Pan-Cancer Analysis Identifies Centromere-Associated Protein E As a Novel Prognostic and Immunological Biomarker in Human Tumors.

Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma

[Centromere Protein U is Highly Expressed in Colorectal Cancer and Associated with a Poor Long-Term Prognosis].

High CENPM Mrna Expression and Its Prognostic Significance in Hepatocellular Carcinoma: a Study Based on Data Mining

Significance of centromere protein genes and their associated immune and metabolic differences in the prediction of prognosis and treatment outcome in breast cancer